XACT Carotid Stent System
Abbott Vascular, Inc. · Decision date Aug 25, 2025
What did the FDA decide?
FDA records P040038/S049 as a supplement to PMA P040038, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 25, 2025.
FDA approval order statement
to transfer delivery system component manufacturing to in-house and for minor changes to raw material specifications
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 25, 2025
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P040038/S049
- Regulatory pathway
- PMA supplement
- Applicant
- Abbott Vascular, Inc.
- Product code
- NIM
- Decision code
- OK30
- Decision date
- Aug 25, 2025
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stent, carotid.
- Applicant
- Abbott Vascular, Inc.
- Product code
- NIM
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P040038/S049 received
Application receipt date recorded by FDA.
P040038/S049 · FDA decision
30-Day Notice
P040038/S050 · Related supplement
XACT Carotid Stent System (XACT CSS) and XACT Transcarotid Stent System (XACT TSS)
P040038/S048 · Related supplement
XACT Carotid Stent System
P040038/S051 · Related supplement
XACT Carotid Stent System
Timeline entries are records held by MedtechLedger for P040038. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P040038
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Abbott Vascular, Inc. | PMA supplement | Oct 17, 2025 | FDA | |
XACT Carotid Stent SystemP040038/S048 | Abbott Vascular, Inc. | PMA supplement | Dec 9, 2025 | FDA |
XACT Carotid Stent SystemP040038/S051 | Abbott Vascular, Inc. | PMA supplement | Mar 20, 2026 | FDA |
Explore the linked device profile
Other records with product code NIM
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMSP060001/S060 | Medtronic Vascular, Inc. | PMA supplement | Nov 5, 2026 | FDA |
| Contego Medical, Inc. | PMA supplement | Nov 4, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Oct 16, 2026 | FDA | |
| Contego Medical, Inc. | PMA supplement | Jul 29, 2026 | FDA | |
| Medtronic Vascular, Inc. | PMA supplement | Jul 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Vascular, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 3200 Lakeside Dr., Santa Clara, CA, 95054
Sources and methodology
- Original FDA record: P040038/S049
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



